Identification and functional study of a new missense mutation in the motor head domain of myosin VIIA in a family with autosomal dominant hearing impairment (DFNA11)

PLoS One. 2013;8(1):e55178. doi: 10.1371/journal.pone.0055178. Epub 2013 Jan 29.

Abstract

The MYO7A encodes a protein classified as an unconventional myosin. Here, we present a family with non-syndromic autosomal dominant hearing impairment that clinically resembles other previously published DFNA11 families. Affected members of the family present with an ascending audiogram affecting low and middle frequencies at young ages and then affecting all frequencies with increasing age. Genome-wide linkage analysis using Illumina Cyto-12 Chip mapped the disease locus to the DFNA11 interval in the family. A c.2003G→A (p.R668H) mutation of the MYO7A, is heterozygous in all affected family members and absent in 100 healthy individuals. Arg668His is located in a region of the myosin VIIA motor domain that is highly conserved among different species. Molecular modeling predicts that the conserved R668 residue plays important structural role in linking different lobes of motor domain together. In the actin-activated ATPase activity assay, the rate of NADH oxidation was higher in the wild-type myosin VIIA, indicating that the ATPase activity in the p.R668H mutant myosin VIIA was significantly destroyed.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asian People / genetics
  • Chromosomes, Human, Pair 11 / genetics*
  • DNA Mutational Analysis
  • Female
  • Genetic Linkage
  • Hearing Loss, Sensorineural / genetics*
  • Humans
  • Lod Score
  • Male
  • Models, Molecular*
  • Mutation, Missense / genetics*
  • Myosin VIIa
  • Myosins / genetics*
  • Pedigree
  • Protein Conformation*

Substances

  • MYO7A protein, human
  • Myosin VIIa
  • Myosins

Supplementary concepts

  • Deafness, Autosomal Dominant 11

Grants and funding

This work was supported by a grant from the National Basic Research Program of China (2011CB504502, 2011CB504506), the National High Technology Research and Development Program of China (863 Program) 2011AA02A112 ), the National Natural Science Foundation of China (81100467, 81270747, 81070793, 81230019), the Program for Changjiang Scholars and Innovative Research Team in Universities (IRT1010), the Innovation Programme of Major Basic Research Projects, the Program of Outstanding Shanghai Academic Leaders (11XD1401300) and the Program of Leading Medical Personnel in Shanghai, the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601, 09DJ1400602) and the General Financial Grant from the China Postdoctoral Science Foundation (2012M512064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.